LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/Antidepressants, Anti-Anxiety Drugs Causing More Hip Fractures?
Large Joints and Extremities

Antidepressants, Anti-Anxiety Drugs Causing More Hip Fractures?

March 28, 2017 1 min read Premium comments

Advertisement

Antidepressants, Anti-Anxiety Drugs Causing More Hip Fractures?
Source: Wikimedia Commons and Tom Varco
Secondary

New research from Norway has found that older individuals who had fallen and broken a hip used antidepressant and anti-anxiety medications more frequently than those in the general older population.

The article, entitled, “Psychotropics and weak opioid analgesics in plasma samples of older hip fracture patients–detection frequencies and consistency with drug records,” was published in the British Journal of Clinical Pharmacology.

The researchers examined plasma from 250 hip fracture patients over 65, using ultra-performance liquid chromatography–tandem mass spectrometry to detect psychotropic drugs and weak opioids (including alcohol).

According to the March 7, 2017 news release, “The analysis measured drug levels in individuals’ blood samples, which provided investigators with a more precise measure than asking participants if they took the medications or examining their medical records. Indeed, the drugs were often present in these samples despite no information in patients’ medical records.”

“…Several of the detected drugs increase the risk of falling, which underscores the clinical relevance of these findings,” said Ragnhild Birkeland Waade of the Center for Psychopharmacology at Diakonhjemmet Hospital in Oslo, Norway.

Dr. Waade, lead author of the study told OTW, “We were surprised to learn that so many patients had centrally acting drugs in their blood without doctors being aware of this use. It is important for orthopedic surgeons to be aware of the potential presence of centrally acting drugs in the patients’ blood at hospitalization as this could influence on the choice and dosing of drugs during surgery.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy